These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 12100475)
61. [Amyloid P components in normal human skin and skin with lesions]. Hintner H; Breathnach SM Hautarzt; 1988 Nov; 39(11):712-6. PubMed ID: 3072321 [TBL] [Abstract][Full Text] [Related]
62. Ultrastructure of human C4-binding protein: proposition for a new model. Villiers MB; Thielens NM; Villiers CL; Colomb MG Eur J Immunol; 1985 Sep; 15(9):941-5. PubMed ID: 4043205 [TBL] [Abstract][Full Text] [Related]
63. Calcium-mediated hemagglutination by serum amyloid P component and the inhibition by specific glycosaminoglycans. Hamazaki H Biochem Biophys Res Commun; 1988 Jan; 150(1):212-8. PubMed ID: 3276308 [TBL] [Abstract][Full Text] [Related]
64. Serum Amyloid P and IgG Exhibit Differential Capabilities in the Activation of the Innate Immune System in Response to Bacillus anthracis Peptidoglycan. Girton AW; Popescu NI; Keshari RS; Burgett T; Lupu F; Coggeshall KM Infect Immun; 2018 May; 86(5):. PubMed ID: 29531132 [TBL] [Abstract][Full Text] [Related]
65. Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins. Hillarp A; Wiklund H; Thern A; Dahlbäck B J Immunol; 1997 Feb; 158(3):1315-23. PubMed ID: 9013975 [TBL] [Abstract][Full Text] [Related]
66. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein. Li XA; Yutani C; Shimokado K Biochem Biophys Res Commun; 1998 Mar; 244(1):249-52. PubMed ID: 9514915 [TBL] [Abstract][Full Text] [Related]
67. Amyloid P component. Skinner M; Cohen AS Methods Enzymol; 1988; 163():523-36. PubMed ID: 3237088 [No Abstract] [Full Text] [Related]
68. Binding of Ca2+, Mg2+, and heparin by human serum amyloid P component in affinity capillary electrophoresis. Heegaard NH; He X; Blomberg LG Electrophoresis; 2006 Jul; 27(13):2609-15. PubMed ID: 16817162 [TBL] [Abstract][Full Text] [Related]
69. Ligand-assisted aggregation of proteins. Dimerization of serum amyloid P component by bivalent ligands. Ho JG; Kitov PI; Paszkiewicz E; Sadowska J; Bundle DR; Ng KK J Biol Chem; 2005 Sep; 280(36):31999-2008. PubMed ID: 16036920 [TBL] [Abstract][Full Text] [Related]
70. Glycosaminoglycan Neutralization in Coagulation Control. Sobczak AIS; Pitt SJ; Stewart AJ Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1258-1270. PubMed ID: 29674476 [TBL] [Abstract][Full Text] [Related]
71. Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human plasma. Bergsma D; Chen S; Buchweitz J; Gerszten R; Haab BB Mol Cell Proteomics; 2010 Mar; 9(3):446-56. PubMed ID: 20023212 [TBL] [Abstract][Full Text] [Related]
73. Serum amyloid p component does not circulate in complex with C4-binding protein, fibronectin or any other major protein ligand. Sen JW; Heegaard NH Scand J Immunol; 2002 Jul; 56(1):85-93. PubMed ID: 12100475 [TBL] [Abstract][Full Text] [Related]
74. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. de Beer FC; Baltz ML; Holford S; Feinstein A; Pepys MB J Exp Med; 1981 Oct; 154(4):1134-9. PubMed ID: 6793685 [TBL] [Abstract][Full Text] [Related]
75. Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase. Sørensen IJ; Nielsen EH; Andersen O; Danielsen B; Svehag SE Scand J Immunol; 1996 Oct; 44(4):401-7. PubMed ID: 8845035 [TBL] [Abstract][Full Text] [Related]
76. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose. Hind CR; Collins PM; Renn D; Cook RB; Caspi D; Baltz ML; Pepys MB J Exp Med; 1984 Apr; 159(4):1058-69. PubMed ID: 6707579 [TBL] [Abstract][Full Text] [Related]